Trial Profile
A Double-Blind, Randomized, Parallel Design Study To Assess the Safety and Pharmacokinetics of Terbinafine Hydrogen Cloride (HCl) Nail Lacquer Applied for 28 Days in Patients With Onychomycosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Oct 2014
Price :
$35
*
At a glance
- Drugs Terbinafine (Primary) ; Terbinafine (Primary) ; Terbinafine (Primary)
- Indications Onychomycosis; Tinea pedis
- Focus Adverse reactions
- Sponsors Apricus Biosciences
- 27 May 2014 New trial record